Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Bedrock Bedrock +19.53%
#4 Cysic Cysic +19.17%
#5 Fabric Protocol Fabric Protocol +15.42%
#6 Perle Perle +8.92%
#7 Nockchain Nockchain +8.81%
#8 Arowana Arowana +8.41%
#9 Velvet Velvet +6.80%
#10 stake.link stake.link +6.79%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Fuse Medical, Inc. Fuse Medical, Inc.

Fuse Medical, Inc.

FZMD
Rank in Stocks #37740
Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based... Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.
Share Price
$0.02
Last synced: 2026-08-13
Market Cap
$1.48M
Change (1 day)
0.00%
Change (1 year)
-71.43%
Country
US
Trade Fuse Medical, Inc. (FZMD)

Category

Healthcare
P/E ratio for Fuse Medical, Inc. (FZMD)
P/E ratio as of 2026 TTM: 0
According to Fuse Medical, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Fuse Medical, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 33.99 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 33.47 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 18.84 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 49.47 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.